Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Seher

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2010
Soluble and transmembrane TNF-like weak inducer of apoptosis differentially activate the classical and noncanonical NF-kappa B pathwayClaudia Roos, Andreas Wicovsky, Nicole Müller, et al.
International Journal of Molecular Sciences|March 17, 2019
The Selection of NFκB Inhibitors to Block Inflammation and Induce Sensitisation to FasL-Induced Apoptosis in HNSCC Cell Lines Is Critical for Their Use as a Prospective Cancer TherapyMario Joachim Johannes Scheurer, Roman Camillus Brands, Mohamed El-Mesery, et al.
Molecular Medicine Reports|January 20, 2016
Co-treatment of wild-type EGFR head and neck cancer cell lines with afatinib and cisplatinRoman C Brands, Urs D A Müller-Richter, Francesco De Donno, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|August 8, 2019
Targeting inhibitors of apoptosis in oral squamous cell carcinoma in vitroMario J J Scheurer, Axel Seher, Valentin Steinacker, et al.
Clinical Oral Investigations|September 16, 2016
The prognostic value of GLUT-1 staining in the detection of malignant transformation in oral mucosaRoman C Brands, Olga Köhler, Stephan Rauthe, et al.
Oncology Reports|July 18, 2017
Targeting VEGFR and FGFR in head and neck squamous cell carcinoma in vitroRoman C Brands, Luise M Knierim, Francesco De Donno, et al.
International Journal of Molecular Medicine|April 16, 2015
MAGE-A expression clusters and antineoplastic treatment in head and neck cancerStefan Hartmann, Till J Meyer, Roman C Brands, et al.
Oncology Letters|August 28, 2019
Multi-kinase inhibitors and cisplatin for head and neck cancer treatment <i>in vitro</i>Roman C Brands, Francesco De Donno, Marie Luise Knierim, et al.
Cells|February 15, 2022
Low Energy Status under Methionine Restriction Is Essentially Independent of Proliferation or Cell Contact InhibitionCorinna Koderer, Werner Schmitz, Anna Chiara Wünsch, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|February 3, 2019
MicroRNA expression correlates with disease recurrence and overall survival in oral squamous cell carcinomaJulius Moratin, Stefan Hartmann, Roman C Brands, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2010
Soluble and transmembrane TNF-like weak inducer of apoptosis differentially activate the classical and noncanonical NF-kappa B pathwayClaudia Roos, Andreas Wicovsky, Nicole Müller, et al.
International Journal of Molecular Sciences|March 17, 2019
The Selection of NFκB Inhibitors to Block Inflammation and Induce Sensitisation to FasL-Induced Apoptosis in HNSCC Cell Lines Is Critical for Their Use as a Prospective Cancer TherapyMario Joachim Johannes Scheurer, Roman Camillus Brands, Mohamed El-Mesery, et al.
Molecular Medicine Reports|January 20, 2016
Co-treatment of wild-type EGFR head and neck cancer cell lines with afatinib and cisplatinRoman C Brands, Urs D A Müller-Richter, Francesco De Donno, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|August 8, 2019
Targeting inhibitors of apoptosis in oral squamous cell carcinoma in vitroMario J J Scheurer, Axel Seher, Valentin Steinacker, et al.
Clinical Oral Investigations|September 16, 2016
The prognostic value of GLUT-1 staining in the detection of malignant transformation in oral mucosaRoman C Brands, Olga Köhler, Stephan Rauthe, et al.
Oncology Reports|July 18, 2017
Targeting VEGFR and FGFR in head and neck squamous cell carcinoma in vitroRoman C Brands, Luise M Knierim, Francesco De Donno, et al.
International Journal of Molecular Medicine|April 16, 2015
MAGE-A expression clusters and antineoplastic treatment in head and neck cancerStefan Hartmann, Till J Meyer, Roman C Brands, et al.
Oncology Letters|August 28, 2019
Multi-kinase inhibitors and cisplatin for head and neck cancer treatment <i>in vitro</i>Roman C Brands, Francesco De Donno, Marie Luise Knierim, et al.
Cells|February 15, 2022
Low Energy Status under Methionine Restriction Is Essentially Independent of Proliferation or Cell Contact InhibitionCorinna Koderer, Werner Schmitz, Anna Chiara Wünsch, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|February 3, 2019
MicroRNA expression correlates with disease recurrence and overall survival in oral squamous cell carcinomaJulius Moratin, Stefan Hartmann, Roman C Brands, et al.
Pageof 4